ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,296 | -24.5% | 96,432 | -5.9% | 0.00% | – |
| Q2 2023 | $383,388 | -16.2% | 102,510 | -24.9% | 0.00% | – |
| Q1 2023 | $457,352 | -45.5% | 136,523 | -21.7% | 0.00% | – |
| Q4 2022 | $838,604 | +14.7% | 174,346 | +35.7% | 0.00% | – |
| Q3 2022 | $731,000 | +127.7% | 128,479 | +183.9% | 0.00% | – |
| Q2 2022 | $321,000 | +18.5% | 45,253 | +20.6% | 0.00% | – |
| Q1 2022 | $271,000 | -75.6% | 37,513 | -69.8% | 0.00% | – |
| Q4 2021 | $1,112,000 | -11.0% | 124,378 | +249.1% | 0.00% | – |
| Q3 2021 | $1,249,000 | -10.4% | 35,630 | -45.1% | 0.00% | – |
| Q2 2021 | $1,394,000 | -7.1% | 64,899 | +167.0% | 0.00% | – |
| Q1 2021 | $1,501,000 | +153.1% | 24,310 | +71.3% | 0.00% | – |
| Q4 2020 | $593,000 | – | 14,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $17,648,000 | 2.07% |
| EcoR1 Capital, LLC | 6,340,639 | $45,019,000 | 1.55% |
| CM Management, LLC | 200,000 | $1,420,000 | 1.51% |
| K2 PRINCIPAL FUND, L.P. | 1,606,059 | $11,403,000 | 1.26% |
| Cormorant Asset Management, LP | 1,547,181 | $10,985,000 | 0.83% |
| Privium Fund Management (UK) Ltd | 61,284 | $435,000 | 0.49% |
| Atom Investors LP | 30,911 | $219,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,588,131 | $25,476,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 347,612 | $2,468,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,799,507 | $12,777,000 | 0.04% |